COLOPLAST -B- receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Coloplast A/S (COLOBc)
Coloplast A/S stock price live, this page displays CSE COLOb stock exchange data. View the COLOb premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Coloplast A/S real time stock price chart below.
What Is the Coloplast A/S Stock Price Today?
The Coloplast A/S stock price today is 618.30.
What Is the Stock Symbol for Coloplast A/S?
The stock symbol for Coloplast A/S is ""COLOb.""
What Stock Exchange Does Coloplast A/S Trade On?
Coloplast A/S is listed and trades on the Copenhagen stock exchange.
Is Coloplast A/S a Good Stock to Buy?
Determining whether Coloplast A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the COLOb quote. (ISIN: DK0060448595)
What Is the Coloplast A/S Stock Price Today?
The Coloplast A/S stock price today is 618.30.
What Is the Stock Symbol for Coloplast A/S?
The stock symbol for Coloplast A/S is ""COLOb.""
What Stock Exchange Does Coloplast A/S Trade On?
Coloplast A/S is listed and trades on the Copenhagen stock exchange.
Is Coloplast A/S a Good Stock to Buy?
Determining whether Coloplast A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the COLOb quote. (ISIN: DK0060448595)
618.30
+5.30(+0.86%)
Closed·
Fair Value
An estimate of a Coloplast A/S's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
617.40
618.70
52 wk Range
583.10
956.20
COLOBc Scorecard
Full Analysis
Has raised its dividend for 16 consecutive years
COLOBc is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Coloplast A/S's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
617.40618.70
52 wk Range
583.10956.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.56%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.56%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
COLOBc Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Coloplast A/S's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- COLOPLAST -B- receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Coloplast A receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- COLOPLAST -B- receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Coloplast A receives Investment Bank Analyst Rating Update
- Investing.com
Pro - COLOPLAST -B- receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Coloplast A/S Company Profile
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Compare COLOBc to Peers and Sector
Metrics to compare | COLOBc | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCOLOBcPeersSector | |
|---|---|---|---|---|
P/E Ratio | 30.6x | 29.5x | −0.5x | |
PEG Ratio | −3.08 | 0.31 | 0.00 | |
Price/Book | 8.2x | 2.3x | 2.6x | |
Price / LTM Sales | 5.0x | 2.7x | 3.2x | |
Upside (Analyst Target) | - | 0.0% | 41.4% | |
Fair Value Upside | Unlock | 28.3% | 6.0% | Unlock |
Earnings
Latest Release
May 06, 2025
EPS / Forecast
4.34 / 5.39
Revenue / Forecast
6.93B / 7.01B
People Also Watch
FAQ
What Stock Exchange Does Coloplast A/S Trade On?
Coloplast A/S is listed and trades on the BATS Europe stock exchange.
What Is the Stock Symbol for Coloplast A/S?
The stock symbol for Coloplast A/S is "COLOBc."
What Is the Coloplast A/S Market Cap?
As of today, Coloplast A/S market cap is 139.24B.
What Is Coloplast A/S's Earnings Per Share (TTM)?
The Coloplast A/S EPS (TTM) is 20.17.
When Is the Next Coloplast A/S Earnings Date?
Coloplast A/S will release its next earnings report on 18 Aug 2025.
From a Technical Analysis Perspective, Is COLOBc a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Coloplast A/S Stock Split?
Coloplast A/S has split 1 times.
How Many Employees Does Coloplast A/S Have?
Coloplast A/S has 16741 employees.
What is the current trading status of Coloplast A/S (COLOBc)?
As of 27 Jul 2025, Coloplast A/S (COLOBc) is trading at a price of 618.30, with a previous close of 613.00. The stock has fluctuated within a day range of 617.40 to 618.70, while its 52-week range spans from 583.10 to 956.20.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.